GX-188E DNA Vaccination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GX-188E DNA Vaccination, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy [Phase 2]